Campbell & Co Investment Adviser’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-25,522	Closed	-$301K	–	1221
2024 Q2	$301K	Buy	25,522 +15,518	+155%	+$183K	0.03%	828
2024 Q1	$119K	Sell	10,004 -31,361	-76%	-$372K	0.01%	1055
2023 Q4	$507K	Buy	+41,365	New	+$507K	0.05%	705